ReviewCureus2025
Selective Laser Trabeculoplasty Versus Pattern Scanning Laser Trabeculoplasty for Reducing Intraocular Pressure in Primary Open-Angle Glaucoma.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Selective laser trabeculoplasty (SLT) significantly lowers the intraocular pressure (IOP) in open-angle glaucoma patients compared to pattern scanning laser trabeculoplasty (PSLT). This review contains results from randomized control trials and a retrospective database analysis obtained through PubMed and Google Scholar. PubMed searches used the following words and terms: "selective laser trabeculoplasty" AND "pattern scanning trabeculoplasty." A similar search on Google Scholar eventually uncovered one additional study comparing the two trabeculoplasty methods. All studies included patients diagnosed with primary open-angle glaucoma (POAG) or ocular hypertension. SLT has not consistently shown superiority over PSLT in managing POAG. PSLT may result in slightly greater short-term reductions in IOP. Patients often report less discomfort with this method, suggesting it may be more tolerable. Both treatments can lead to meaningful reductions in IOP from baseline, which is generally considered a positive treatment outcome. SLT and PSLT were shown to exert the same efficacy. In terms of treatment, both procedures are efficient and beneficial for lowering IOP. PSLT was favored to be more tolerable in one of the studies. Further research is required to observe potential side effects, long-term treatment, and mechanisms of action of both lasers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.